Ligand validation:5IY5

TGL: TRISTEAROYLGLYCEROL

TGL is a Ligand Of Interest in 5IY5 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5IY5_TGL_B_301	41%	21%	0.182	0.899	1.45	1.87	8	13	2	0	100%	1
5IY5_TGL_N_608	26%	17%	0.193	0.835	1.48	2.09	8	14	0	0	100%	1
5IY5_TGL_D_201	13%	28%	0.219	0.757	1.39	1.51	6	8	7	0	100%	1
5IY5_TGL_Q_201	13%	32%	0.208	0.742	1.4	1.29	6	9	6	0	100%	1
5IY5_TGL_L_101	12%	24%	0.257	0.783	1.56	1.58	6	14	7	0	100%	1
5B1A_TGL_B_301	58%	8%	0.119	0.898	1.71	2.82	8	21	2	0	100%	1
5ZCQ_TGL_A_608	51%	22%	0.146	0.899	1.36	1.87	5	11	1	0	100%	1
5ZCP_TGL_A_608	49%	17%	0.149	0.895	1.31	2.24	6	10	1	0	100%	1
5B3S_TGL_B_301	48%	36%	0.154	0.897	1.1	1.4	3	6	3	0	100%	1
6JUW_TGL_A_610	48%	36%	0.137	0.878	1.18	1.34	3	6	0	0	100%	1
7W3E_TGL_B_301	46%	30%	0.145	0.881	1.18	1.61	3	9	2	0	98%	0.9841

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.